BidaskClub upgraded shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) from a strong sell rating to a sell rating in a research note issued to investors on Friday morning.

Several other research firms also recently commented on WBA. Raymond James Financial, Inc. reissued a market perform rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. Leerink Swann downgraded Walgreens Boots Alliance from an outperform rating to a market perform rating in a research note on Wednesday, November 1st. Loop Capital set a $90.00 price objective on Walgreens Boots Alliance and gave the company a buy rating in a research note on Thursday, October 26th. SunTrust Banks, Inc. set a $72.00 price objective on Walgreens Boots Alliance and gave the company a hold rating in a research note on Sunday, October 15th. Finally, Pivotal Research reduced their price objective on Walgreens Boots Alliance from $85.00 to $73.00 and set a hold rating for the company in a research note on Tuesday, October 24th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the company. The company has a consensus rating of Buy and a consensus price target of $87.63.

Walgreens Boots Alliance (NASDAQ:WBA) opened at $70.37 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. The firm has a market capitalization of $71,667.88, a P/E ratio of 13.92, a PEG ratio of 1.26 and a beta of 1.20. Walgreens Boots Alliance has a 52 week low of $63.82 and a 52 week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. During the same period in the prior year, the company posted $1.07 EPS. The business’s quarterly revenue was up 5.3% on a year-over-year basis. research analysts anticipate that Walgreens Boots Alliance will post 5.55 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This news story was published by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-upgraded-to-sell-by-bidaskclub/1701434.html.

Walgreens Boots Alliance declared that its board has initiated a stock buyback program on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company’s management believes its shares are undervalued.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is presently 42.33%.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John Anthony Lederer purchased 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The stock was bought at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. 13.50% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of WBA. Hudock Capital Group LLC raised its position in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares in the last quarter. Westside Investment Management Inc. raised its position in Walgreens Boots Alliance by 10.4% in the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 125 shares in the last quarter. Reilly Financial Advisors LLC raised its position in Walgreens Boots Alliance by 7.9% in the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock valued at $107,000 after purchasing an additional 100 shares in the last quarter. Orrstown Financial Services Inc. raised its position in Walgreens Boots Alliance by 14.1% in the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock valued at $135,000 after purchasing an additional 213 shares in the last quarter. Finally, IHT Wealth Management LLC raised its position in Walgreens Boots Alliance by 46.3% in the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after purchasing an additional 2,199 shares in the last quarter. 63.58% of the stock is currently owned by institutional investors.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.